Finance ❯ Investments ❯ Stock Market
Securities Fraud Class Action Lawsuits Market Reactions Legal Recourse Securities Class Action Legal Claims Securities Litigation Securities Laws Securities Lawsuits Market Capitalization uniQure Stock uniQure Securities Securities Transactions Corporate Performance Securities Class Actions Class Action Participation Kyndryl Securities Enphase Stock Market Analysis Class Action Settlements Litigation Costs Securities Securities Regulations Securities Trading Lockheed Martin Corporation Tronox Holdings PLC PayPal Stock Market Regulations
Want to see what podcasts are saying about this topic? Search across 135K+ podcasts. Explore Radar
Plaintiffs say Embecta misrepresented the basis for its Q2 and full‑year 2026 guidance by downplaying concentrated customer losses and retail weakness in its insulin pen and pen‑needle business.
